GPAINNOVA was born in 2013. Its founding aim was to become a technological platform, based on an expert team composed by engineers, scientists and specialty experts, devoted to provide a reliable innovation resource hub to create the necessary synergies and boost the most innovative and ambitious technological projects for GPAINNOVA and selected partners. During April 2020, in the midst of COVID-19’s first wave, GPAINNOVA initiated a new project committed to support public health and ease supplies stress occurred to hospitals and governments, given the lack of medical ventilators. GPA Medical is a spin-off created upon the release of its first product to contribute fight to protect patient’s life requiring mechanical ventilation as, for instance, due to COVID-19’s pneumonia. RESPIRA device. Advanced’s disruptive invention is the first high-performance ventilator based on the automation of a manual resuscitation device,by such ease of deployment, comprehensive use to non-expert physicians as well as sterilization ease dramatically increases providing immediate ventilation in case of need. In order to develop this medical device, GPAINNOVA had the privilege to cooperate with key players on the respective fields; World Class BarBarcelona University Hospitals provided all their medical knowledge and support whilst SIEMENS DI became the strategic technological partner providing the most outstanding hardware and software solutions. Upon completion of all trials, technical file and regulatory procedures, this medical device has been patented (pat. pending)